Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.70%270.14M | -6.64%518.52M | -7.23%237.59M | -6.13%555.38M | 3.36%256.11M | -18.74%591.67M | -34.44%247.79M | -18.27%728.14M | -0.37%377.93M | -49.11%890.91M |
| Operating income | 13.70%270.14M | -6.64%518.52M | -7.23%237.59M | -6.13%555.38M | 3.36%256.11M | -18.74%591.67M | -34.44%247.79M | -18.27%728.14M | -0.37%377.93M | -49.11%890.91M |
| Cost of sales | -17.35%-228.08M | 6.21%-431.26M | 8.48%-194.36M | 6.22%-459.81M | 0.65%-212.36M | 21.63%-490.32M | 35.05%-213.76M | 20.85%-625.69M | 5.97%-329.14M | 50.92%-790.48M |
| Operating expenses | -17.35%-228.08M | 6.21%-431.26M | 8.48%-194.36M | 6.22%-459.81M | 0.65%-212.36M | 21.63%-490.32M | 35.05%-213.76M | 20.85%-625.69M | 5.97%-329.14M | 50.92%-790.48M |
| Gross profit | -2.70%42.07M | -8.70%87.26M | -1.18%43.23M | -5.70%95.57M | 28.56%43.75M | -1.08%101.35M | -30.26%34.03M | 2.01%102.45M | 66.68%48.8M | -28.30%100.44M |
| Selling expenses | 3.66%-15.93M | 7.55%-34.86M | 15.13%-16.54M | 10.27%-37.71M | 7.85%-19.49M | 32.89%-42.02M | 28.13%-21.15M | 34.33%-62.62M | 34.79%-29.43M | 43.80%-95.34M |
| Administrative expenses | -56.78%-51.05M | -29.99%-85.3M | -16.73%-32.56M | -15.14%-65.62M | -0.19%-27.9M | 6.32%-56.99M | 16.62%-27.84M | 16.26%-60.83M | 16.44%-33.4M | 29.13%-72.64M |
| Impairment and provision | -84.93%-2.26M | 52.84%-32.7M | -231.57%-1.22M | -121.30%-69.34M | 33.33%928K | -109.21%-31.33M | 118.80%696K | 94.99%-14.98M | 98.95%-3.7M | -1,761.59%-298.67M |
| -Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.85M | ---- | ---- |
| -Other impairment is provision | -84.93%-2.26M | 52.84%-32.7M | -231.57%-1.22M | -121.30%-69.34M | 33.33%928K | -1,375.14%-31.33M | 118.80%696K | 99.29%-2.12M | 98.95%-3.7M | -1,761.59%-298.67M |
| Special items of operating profit | -515.84%-14.73M | 1.63%18.95M | -70.01%3.54M | 19.47%18.64M | -0.39%11.81M | 162.63%15.61M | 1,863.08%11.86M | 21.82%-24.92M | -95.95%604K | -867.45%-31.87M |
| Operating profit | -1,081.70%-41.9M | 20.19%-46.65M | -138.94%-3.55M | -336.46%-58.46M | 478.35%9.11M | 78.00%-13.39M | 85.94%-2.41M | 84.71%-60.89M | 95.65%-17.13M | -176.53%-398.1M |
| Financing cost | 1.57%-10.34M | 16.12%-21.15M | 11.10%-10.5M | 17.35%-25.21M | 21.06%-11.81M | -17.85%-30.51M | 8.54%-14.97M | 39.28%-25.89M | 22.57%-16.36M | 32.75%-42.63M |
| Share of profits of associates | -278,500.00%-2.79M | -351,300.00%-3.51M | ---1K | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -291.65%-55.03M | 14.76%-71.32M | -419.02%-14.05M | -90.59%-83.67M | 84.42%-2.71M | 49.41%-43.9M | 48.12%-17.37M | 80.31%-86.77M | 91.92%-33.49M | -112.55%-440.73M |
| Tax | 82.98%-353K | 88.87%-526K | 19.02%-2.07M | -21.27%-4.73M | -221.73%-2.56M | 75.58%-3.9M | 38.82%-796K | 28.37%-15.96M | -164.86%-1.3M | -165.92%-22.28M |
| After-tax profit from continuing operations | -243.46%-55.38M | 18.73%-71.84M | -206.07%-16.12M | -84.94%-88.4M | 71.01%-5.27M | 53.47%-47.8M | 47.78%-18.17M | 77.81%-102.73M | 91.56%-34.79M | -166.79%-463.01M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 229.37%13.78M | ---5.15M | 70.14%-10.65M |
| Earning after tax | -243.46%-55.38M | 18.73%-71.84M | -206.07%-16.12M | -84.94%-88.4M | 71.01%-5.27M | 46.27%-47.8M | 54.50%-18.17M | 81.22%-88.95M | 90.32%-39.94M | -126.40%-473.66M |
| Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 34.24%-1.11M | ---232K | 87.57%-1.69M |
| Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 41.67%-3.04M | ---2.57M | -15.82%-5.22M |
| Minority profit | -553.62%-1.35M | -264.22%-3.92M | -417.50%-207K | -252.41%-1.08M | 88.41%-40K | 116.99%706K | 87.67%-345K | 39.86%-4.16M | 50.50%-2.8M | 61.83%-6.91M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 77.97%-101.62M | ---34.56M | -188.42%-461.32M |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 409.70%16.82M | ---2.58M | 82.57%-5.43M |
| Profit attributable to shareholders | -239.43%-54.03M | 22.21%-67.92M | -204.46%-15.92M | -80.03%-87.32M | 70.67%-5.23M | 42.80%-48.5M | 52.00%-17.82M | 81.83%-84.8M | 90.87%-37.14M | -144.23%-466.75M |
| Basic earnings per share | -244.44%-0.0031 | 23.53%-0.0039 | -200.00%-0.0009 | 25.00%-0.0051 | 88.46%-0.0003 | 45.60%-0.0068 | 52.73%-0.0026 | 81.88%-0.0125 | 90.85%-0.0055 | -144.68%-0.069 |
| Diluted earnings per share | -244.44%-0.0031 | 23.53%-0.0039 | -200.00%-0.0009 | 25.00%-0.0051 | 88.46%-0.0003 | 45.60%-0.0068 | 52.73%-0.0026 | 81.88%-0.0125 | 90.85%-0.0055 | -144.68%-0.069 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm | -- | Guowei Certified Public Accountants | -- | Guowei Certified Public Accountants | -- | Guowei Certified Public Accountants | -- | National Health Accounting Firm |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.